Insider Buying: RUA Life Sciences plc (LON:RUA) Insider Acquires £3,250 in Stock

RUA Life Sciences plc (LON:RUA) insider William D. Brown acquired 25,000 shares of the firm’s stock in a transaction that occurred on Monday, February 3rd. The shares were bought at an average cost of GBX 13 ($0.16) per share, for a total transaction of £3,250 ($4,041.79).

RUA Life Sciences Price Performance

RUA stock opened at GBX 13.68 ($0.17) on Friday. The firm has a 50 day moving average of GBX 11.62 and a 200-day moving average of GBX 11.76. The company has a market cap of £8.49 million, a price-to-earnings ratio of -342.00 and a beta of 1.21. The company has a current ratio of 9.01, a quick ratio of 7.32 and a debt-to-equity ratio of 5.42. RUA Life Sciences plc has a 12-month low of GBX 8.50 ($0.11) and a 12-month high of GBX 15.70 ($0.20).

RUA Life Sciences (LON:RUA) last issued its quarterly earnings data on Wednesday, December 11th. The company reported GBX 1.03 ($0.01) earnings per share (EPS) for the quarter. RUA Life Sciences had a negative return on equity of 24.27% and a negative net margin of 65.72%.

RUA Life Sciences Company Profile

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.